BR112013023600A2 - bactérias probióticas tendo atividade antioxidante e uso das mesmas - Google Patents

bactérias probióticas tendo atividade antioxidante e uso das mesmas

Info

Publication number: BR112013023600A2
Authority: BR; Brazil
Prior art keywords: antioxidant activity; probiotic bacteria; probiotic; bacteria; antioxidant
Prior art date: 2011-03-17

Application number

BR112013023600A

Other languages

English (en)

Inventor

Paolo Strozzi Gian

Mogna Giovanni

Mogna Luca

Original Assignee

Probiotical Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-17

Filing date

2011-03-17

Publication date

2017-03-01

2011-03-17 Application filed by Probiotical Spa filed Critical Probiotical Spa

2017-03-01 Publication of BR112013023600A2 publication Critical patent/BR112013023600A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Orthopedic Medicine & Surgery (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Obesity (AREA)
Psychiatry (AREA)
Psychology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)

BR112013023600A 2011-03-17 2011-03-17 bactérias probióticas tendo atividade antioxidante e uso das mesmas BR112013023600A2 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IB2011/000561 WO2012123770A1 (en)	2011-03-17	2011-03-17	Probiotic bacteria having antioxidant activity and use thereof

Publications (1)

Publication Number	Publication Date
BR112013023600A2 true BR112013023600A2 (pt)	2017-03-01

Family

ID=44120141

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112013023600A BR112013023600A2 (pt)	2011-03-17	2011-03-17	bactérias probióticas tendo atividade antioxidante e uso das mesmas

Country Status (10)

Country	Link
US (1)	US20140065116A1 (pt)
EP (1)	EP2685994B1 (pt)
JP (1)	JP2014508186A (pt)
CN (1)	CN103582486B (pt)
BR (1)	BR112013023600A2 (pt)
DK (1)	DK2685994T3 (pt)
ES (1)	ES2561253T3 (pt)
PL (1)	PL2685994T3 (pt)
RU (1)	RU2572698C2 (pt)
WO (1)	WO2012123770A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20110791A1 (it)	2011-05-09	2012-11-10	Probiotical Spa	Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it)	2011-05-09	2012-11-10	Probiotical Spa	Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it)	2011-05-09	2012-11-10	Probiotical Spa	Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20111718A1 (it)	2011-09-23	2013-03-24	Probiotical Spa	Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US20160106789A1 (en) *	2013-03-14	2016-04-21	Gil NOFAR	Inhibition of Neurodegenerative Disease by Grape Seed Extract, Green Tea Extract and Probiotic Bacteria
US20160030493A1 (en) *	2013-03-14	2016-02-04	Gil NOFAR	Inhibition of Neurodegenerative Disease by Grape Seed Extract, Green Tea Extract and Probiotic Bacteria
ITMI20130793A1 (it)	2013-05-14	2014-11-15	Probiotical Spa	Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ES2526986B1 (es) *	2013-07-18	2015-11-02	Biopolis, S.L.	Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
CN103961338B (zh) *	2014-04-03	2016-01-06	浙江大学	羟基酪醇在抗阿霉素心肌毒性中的应用及以羟基酪醇为主要活性成分的药物组合物
CN104172177A (zh) *	2014-06-11	2014-12-03	南通昊友食品添加剂有限公司	一种食品抗氧化剂的生产方法
AP2016009641A0 (en)	2014-07-01	2016-12-31	Probi Usa Inc	Bi-layer dual release probiotic tablets
JP6665099B2 (ja) *	2014-08-29	2020-03-13	わかもと製薬株式会社	乳酸菌含有組成物
CN104522833A (zh) *	2014-12-16	2015-04-22	镇江拜因诺生物科技有限公司	一种微生物食品抗氧化剂的制备方法
TWI788111B (zh)	2015-01-02	2022-12-21	美商梅拉洛伊卡公司	多元補充品組成物
WO2016109853A2 (en)	2015-01-02	2016-07-07	Melaleuca, Inc.	Dietary supplement compositions
TWI790189B (zh)	2015-01-02	2023-01-21	美商梅拉洛伊卡公司	細菌組成物
KR101806130B1 (ko) *	2015-05-07	2017-12-08	주식회사 다인소재	유산균발효분말과 허브 추출물을 유효성분으로 하는 육가공용 항균 및 항산화 조성물
KR102160428B1 (ko) *	2015-09-23	2020-09-29	리옥신, 엘엘씨	플라보노이드 조성물 및 사용 방법
US10441621B2 (en)	2015-09-23	2019-10-15	Reoxcyn, Llc	Flavonoid compositions and methods of use
RU2617946C1 (ru) *	2015-11-24	2017-04-28	Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан"	Штаммы Lactobacillus brevis и Lactobacillus rhamnosus с установленной последовательностью генома, синтезирующие глутатион и комплекс внутриклеточных антиоксидантов
MA45334A (fr)	2016-03-24	2019-01-30	Probiotical Spa	Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN106473148A (zh) *	2016-09-14	2017-03-08	吴卓蓉	一种复合益生菌组合物及其制备方法及应用
IT201700068000A1 (it) *	2017-06-19	2018-12-19	Probiotical Spa	Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
CN107593929A (zh) *	2017-10-13	2018-01-19	东北农业大学	一种含有双歧杆菌和嗜酸乳杆菌的抗氧化契达干酪及其制备方法
CN107595921A (zh) *	2017-10-24	2018-01-19	南昌大学	一种复合益生菌发酵的仙人掌果制剂及其在治疗口腔溃疡中的应用
TWI693026B (zh) *	2019-01-07	2020-05-11	大江生醫股份有限公司	黑色素材發酵物及其製備方法與其用於增加抗氧化活性及保護眼睛的用途
IT202000007690A1 (it) *	2020-04-09	2021-10-09	Probiotical Spa	Uso di ceppi di batteri Lactobacillus plantarum e/o Lactobacillus pentosus nella riduzione di una quantità ingerita o accumulata di fosfonati nel microbiota umano
US20230217979A1 (en) *	2022-01-13	2023-07-13	Amare Global	Nutritional supplements and methods of nutritional supplementation affecting weight loss
CN115944085B (zh) *	2022-12-07	2024-08-09	山东奥博森生物药业股份有限公司	一种功能性益生菌组合物及定量添加装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3819838A (en) *	1970-08-04	1974-06-25	Bush Boake Allen Ltd	Encapsulated flavoring composition
CH637297A5 (fr) *	1978-12-05	1983-07-29	Nestle Sa	Microbille comprenant un microorganisme et son procede de fabrication.
US4670272A (en) *	1985-11-08	1987-06-02	Frito-Lay, Inc.	Thermostable creme
WO2001078533A2 (en) *	2000-04-18	2001-10-25	Société des Produits Nestlé S.A.	Nutritional modules
CA2559596A1 (en) *	2003-03-13	2004-11-25	Universite De Moncton (Bureau De Soutien A L'innovation)	Antioxidant producing bacterium and uses thereof
DE50300325D1 (de) *	2003-11-03	2005-03-31	Peter-Hansen Volkmann	Vaginalpflegezusammensetzung
KR100661032B1 (ko) *	2005-04-19	2006-12-22	주식회사한국야쿠르트	간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
EP2210505A1 (en) *	2009-01-27	2010-07-28	Nestec S.A.	Composition comprising caftaric acid and/or derivatives thereof
IT1400821B1 (it) *	2009-03-09	2013-07-02	Probiotical Spa	Sospensione oleosa contenente batteri probiotici per uso pediatrico

2011
- 2011-03-17 BR BR112013023600A patent/BR112013023600A2/pt active Search and Examination
- 2011-03-17 WO PCT/IB2011/000561 patent/WO2012123770A1/en active Application Filing
- 2011-03-17 DK DK11719626.1T patent/DK2685994T3/en active
- 2011-03-17 EP EP11719626.1A patent/EP2685994B1/en active Active
- 2011-03-17 PL PL11719626T patent/PL2685994T3/pl unknown
- 2011-03-17 CN CN201180070870.0A patent/CN103582486B/zh not_active Expired - Fee Related
- 2011-03-17 RU RU2013144267/15A patent/RU2572698C2/ru active
- 2011-03-17 US US14/005,821 patent/US20140065116A1/en not_active Abandoned
- 2011-03-17 JP JP2013558517A patent/JP2014508186A/ja active Pending
- 2011-03-17 ES ES11719626.1T patent/ES2561253T3/es active Active

Also Published As

Publication number	Publication date
US20140065116A1 (en)	2014-03-06
RU2572698C2 (ru)	2016-01-20
EP2685994B1 (en)	2015-12-30
CN103582486A (zh)	2014-02-12
DK2685994T3 (en)	2016-02-01
PL2685994T3 (pl)	2016-05-31
JP2014508186A (ja)	2014-04-03
WO2012123770A1 (en)	2012-09-20
CN103582486B (zh)	2016-11-16
RU2013144267A (ru)	2015-04-27
EP2685994A1 (en)	2014-01-22
ES2561253T3 (es)	2016-02-25

Publication	Publication Date	Title
BR112013023600A2 (pt)	2017-03-01	bactérias probióticas tendo atividade antioxidante e uso das mesmas
SMT201600218B (it)	2016-08-31	Batterio per uso come probiotico per applicazioni nutrizionali e mediche
DK2745743T3 (da)	2017-11-06	Møbelstyring og siddemøbel
BR112016011830A2 (pt)	2017-09-26	composições bacterianas sinergísticas e métodos para produção e uso das mesmas.
HUE054437T2 (hu)	2021-09-28	Anti-CGRP készítmények és alkalmazásuk
BR112015014063A2 (pt)	2018-10-30	anticorpos anti-b7-h4 humano e seus usos.
BR112013007506A2 (pt)	2016-07-12	piridinonas/pirazinonas - métodos de criação e de uso
AP2014007541A0 (en)	2014-03-31	Substituted annellated pyrimidine and the use thereof
EP2940145A4 (en)	2016-10-12	BACTERIAL CELLULOSE AND BACTERIUM FOR THE PRODUCTION THEREOF
DK2366310T3 (da)	2013-01-21	Siddemøbel
HRP20180497T1 (hr)	2018-07-27	Antimikrobni pripravci i odgovarajući postupci njihove upotrebe
BRPI1013432A2 (pt)	2016-04-05	derivado de indolizina e uso do mesmo para propósitos médicos
HRP20171579T8 (hr)	2018-12-14	Antigljivična sredstva i njihova upotreba
BR112015000534A2 (pt)	2017-12-19	método para a preparação de 2,4-dihidroxibutirato, microrganismo, organismo e uso
HRP20180872T1 (hr)	2018-07-13	Životinjska hrana i postupak njezine pripreme
CO7000778A2 (es)	2014-07-21	Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
ZA201307641B (en)	2015-04-29	Human tissue factor antibody and uses thereof
EP2710926A4 (en)	2014-12-10	Simple self-assembly chair for health
DK2437634T3 (da)	2014-04-07	Siddemøbel
IL231444A0 (en)	2014-04-30	Aniline derivativs, their preparation and their therapeutic application
BR112014000773A2 (pt)	2017-06-13	composições de nicotinamida e uso terapêutico das mesmas
EP2854826A4 (en)	2016-07-06	SELECTION AND USE OF MILK ACID BACTERIA FOR PREVENTING BONE REMOVAL IN MAMMALS
BR112013033919A2 (pt)	2017-12-19	combinações e seus usos
DK3205353T3 (da)	2021-04-06	Hurtig- og langtidsvirkende immunologisk terapeutisk middel
BR112013008898A2 (pt)	2016-06-28	benzamidas substituídas e seus usos

Legal Events

Date	Code	Title
2017-10-24	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-02	B07G	Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
2019-05-21	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-09-10	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-03-09	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-06-22	B11D	Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time